Blue Trust Inc’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,000
Closed -$1K 2823
2023
Q4
$1K Hold
1,000
﹤0.01% 2463
2023
Q3
$1K Hold
1,000
﹤0.01% 1992
2023
Q2
$1K Hold
1,000
﹤0.01% 1974
2023
Q1
$3K Hold
1,000
﹤0.01% 1967
2022
Q4
$1K Buy
+1,000
New +$1.72K ﹤0.01% 2182

Blue Trust Inc's ACER Position: Q1 2024 in Review

Blue Trust Inc sold out of Acer Therapeutics Inc (ACER) in Q1 2024, closing a stake of 1,000 shares — an estimated $1K sold.

Blue Trust Inc first reported a position in ACER in Q4 2022 and held it in 5 quarters. The position peaked at $3K in Q1 2023. 1 fund tracked by Wall St. Rank holds ACER as of Q1 2024.

  • Blue Trust Inc reported no remaining Acer Therapeutics Inc position as of Q1 2024 after selling out during the quarter.
  • Blue Trust Inc sold 1,000 Acer Therapeutics Inc shares in Q1 2024, an estimated $1K.
  • Blue Trust Inc first reported a position in Acer Therapeutics Inc in Q4 2022 and held it in 5 quarters.
  • Blue Trust Inc's Acer Therapeutics Inc position peaked at $3K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.